What’s New

Centre for Gastro-intestinal (GI) Bleed launched at Fortis Malar.

“Fortis Malar Hospital opens a dedicated ‘CENTRE FOR GASTRO-INTESTINAL (GI) BLEED

In our continued effort towards reaching greater heights in medical excellence, Fortis Malar Hospital Chennai today opens a dedicated ‘CENTRE FOR GASTRO-INTESTINAL (GI) BLEED’ to perform path-breaking procedures in the field of Gastroenterology. The centre was inaugurated by Mr. Thiru K C Veeramani, Hon’ble Minister for Health, Government of Tamil Nadu.

“The Advanced Centre for GI Bleed’’ at Fortis Malar Hospital comes with an ideal combination of people, processes and technology. Under the expertise of acknowledged and experienced gastroenterologists, this state-of-the-art centre offers diagnosis and treatment for disorders of the digestive tract, which include the esophagus, stomach, small intestine, colon, rectum, pancreas, liver, gallbladder and biliary system.” said Mr. Vijayarathna, Zonal Director, Fortis Malar Hospital

GI Bleed manifests as either vomiting of blood (hematemesis) or passing blood in bowel motions.  Bright red fresh bleeding is readily recognized by patients. However it is important to note that the blood altered due to prolonged stay in the stomach and intestine may appear like coffee grounds in vomiting or as black tar in bowel motions. Patients may experience fainting, breathlessness and weakness.

Since some of the GI Bleeds are life threatening in nature it is of utmost importance that all patients should be properly assessed immediately on arrival, risk stratified and managed accordingly.

  • In case of HIGH RISK bleed, there will be prompt and immediate intervention by senior Interventional Gastroenterologist experienced in diagnosing and effectively treating the condition.
  • It is important to note that the death rate for GI Bleed has been around10%, whereas research has shown that having a dedicated centre for GI Bleed can reduce this by more than 50%.

Our Centre boasts the following features based on International Research & Standards

Time being a crucial factor: we have a

  • 24×7 protocol based assessment and resuscitation
  • Round the clock expert advice and intervention for GI bleeding
  • State of the art treatment modalities for GI Bleed like
  1. Banding for dilated (varicose veins) veins.
  2. Injection/Heater probe/clipping for bleeding ulcers.
  3. Close inputs from radiology & GI Surgery

‘Time being a crucial factor , it is important to have such a combination of international standard protocol based , patient –centered care given by a highly skilled and committed medical team; our centre aims to give best outcomes to our people. ‘Says Dr. P.Basumani, Consultant Medical Gastroenterologist, Fortis Malar Hospital, Chennai.

About Fortis Healthcare Limited

Fortis Healthcare Limited is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 12 countries. Currently, the company operates its healthcare delivery network in India, Hong Kong, Singapore, Vietnam, Dubai, Mauritius, Sri Lanka,   Australia, New Zealand with 70 healthcare facilities (including projects under development), over 11,000 potential beds, over 600 primary care centres, over 190 day care speciality centres, over 240 diagnostic centres, over 22,500 employees together with approximately 2,000 people employed at our managed healthcare facilities.

 

DISCLAIMER

 

This press release may contain forward-looking statements based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Given these risks, uncertainties and other factors, recipients of this press release are cautioned not to place undue reliance on these forward-looking statements. The Company assumes no responsibility to publicly amend, modify or revise any forward looking statements, on the basis of any subsequent development, information or events, or otherwise. The information contained herein is subject to change without notice and past performance is not indicative of future results. The Company may alter, modify or otherwise change in any manner the content of this press release, without obligation to notify any person of such revision or changes.

These materials are not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia). These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in any jurisdiction, including the United States and India. The shares of the Company have not been, and will not be, registered under the United States Securities Act of 1933 (the “Securities Act”).

The Shares may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of securities in any jurisdiction, including the United States and India.”  

Healing Hearts beyond Boundaries

40 year old Pakistani National undergoes complex heart transplant at the Centre of Excellence for Advanced Cardiac Care at Fortis Malar, Chennai.

Key Highlights:

  • 40 year old man with severely depressed heart function
  • Pumping efficiency (Ejection Fraction) less than 15%
  • Hepatitis C infection of the liver,  established Renal Failure and Fungal Infection
  • Difference in the blood group of the donor and recipient, and the recipient was AB+ a rare blood group

Reflecting its commitment to saving and enriching lives beyond boundaries, a team of cardiac experts at the centre of excellence for advanced cardiac care Fortis Malar, Chennai, led by Dr. K R Balakrishnan, Director Cardiac Sciences performed a lifesaving surgery on a Pakistani National who underwent heart transplantation.

40 year old, Moulana Mohammed Zubair Ashmi resident of Tehsil Kharian, District Gujarat, Pakistan, was suffering from a condition called “Dilated Cardiomyopathy”, where the functioning of both the ventricle of the heart is severely depressed. He was repeatedly admitted in several hospitals with breathing difficulty, poor urine output and swelling in the body. Doctors finally diagnosed him as having heart failure and advised his family about heart transplant.

“He had been on medication in Pakistan for more than a year since he was diagnosed with decreased pumping efficiency of the heart of around 10-15 % (Normal being 60 percent) – a condition denoting his poor heart function. When his condition became precarious, he was airlifted from a leading heart hospital in Lahore, Pakistan. Upon his arrival at Fortis Malar, we performed a detailed medical examination, and realised he also had renal failure, had fluid in his lungs and abdomen and was also hepatitis C positive. All this just made his condition extremely difficult to treat” explained Dr. K R Balakrishnan, Director Cardiac Sciences, Fortis Malar. 

Despite being on maximal drugs, his cardiac function was deteriorating, leaving doctors at Fortis Malar with the option of either finding a donor heart urgently or fitting him with an artificial heart implant device. His kidney was nearing ‘shut down’ with a serum creatinine of about 3.8mg% (normal < 1mg %) and scanty urine output of less than 150 cc per day. Since his right ventricle was severely dysfunctional, artificial long term artificial heart pump support was ruled out.

Luckily for Zubair, after a wait of approximately 2 months, a suitable Indian donor heart became available even though it was of a different blood group, thanks to the highly efficient organ sharing network system created in the State by the Govt. of Tamil Nadu.

“If the transplant had been delayed by even 2 days, it would have cost him his life.  Though most of the transplants are usually done on people with same blood group, in Zubair’s case the donor’s blood group was O+ve and his was AB +ve. The tissue mapping in this case was good and viable. His Hepatitis C was treated with Interferon thereby reducing the viral load and Renal disease was managed with Inotropes to increase the renal blood flow and Immuno suppressants was modified to limit damage to the kidneys” added Dr. Suresh Rao, Chief of Cardiac Anesthesia and Critical Care. 

Today Zubair is a happy man and is grateful to God that he was lucky. “I already feel I have got a new lease of life,” he said. Post surgery, he is recuperating well and is able to walk and take food on his own and his kidney function has completely recovered.

“Dr. K R Balakrishan said “There are close to 1.5 million patients diagnosed every year with new onset heart failure in India, and at least a third of them will need advanced therapy to survive.”

“Fortis Malar has one of the best cardiac teams in the country and we look forward to more remarkable milestones in the future” said Mr. Vijayarathna, Zonal Director, Fortis Malar Hospital.

About Dilated Cardiomyopathy

Dilated cardiomyopathy is a condition in which the heart becomes weak, enlarged and cannot pump blood efficiently. It affects the heart’s ventricles and atria. These are the lower and upper chambers of the heart, respectively. The decreased heart function can affect the lungs, liver, and other organs as well. It occurs in people of all ages, including infants and children mostly between the age group of 20 to 60.The disease often starts in the left ventricle, the heart’s main pumping chamber. The heart muscle begins to dilate (stretch and become thinner). This causes the inside of the chamber to enlarge. The problem often spreads to the right ventricle and then to the atria as the disease gets worse.

About Centre of excellence for advanced cardiac care, Fortis Malar Chennai

Fortis Malar Hospital has set benchmarks in cardiac care with its path breaking work over the past 20 years. Today, it is recognized world over as a centre of excellence providing the latest technology in Cardiac Bypass Surgery, Minimally Invasive Surgery, Interventional Cardiology, Non-invasive Cardiology, Paediatrics, Cardiology and Paediatrics Cardiac Surgery. It is amongst the few hospitals in the country that offer specialized treatment in the field of Paediatrics Cardiology and Cardiac Surgery, Heart Transplant and Electrophysiology. 

About Fortis Healthcare Limited

Fortis Healthcare Limited is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 12 countries. Currently, the company operates its healthcare delivery network in India, Hong Kong, Singapore, Vietnam, Dubai, Mauritius, Sri Lanka,   Australia, New Zealand with 70 healthcare facilities (including projects under development), over 11,000 potential beds, over 600 primary care centres, over 190 day care speciality centres, over 240 diagnostic centres, over 22,500 employees together with approximately 2,000 people employed at our managed healthcare facilities

Fortis Malar welcomes Dr Srinath Vijayasekharan, Consultant Cardiothoracic Surgeon

Fortis Malar welcomes Dr Vidyasagaran T, Consultant Vascular Surgeon

Fortis Malar welcomes Dr Ilayakumar, Consultant Vascular Surgeon